Cyclosporine A: good response for patients affected by autoimmune disorders and HCV infection?

Raffaele Manna(Università Cattolica del Sacro Cuore), Antonio Gasbarrini(Università Cattolica del Sacro Cuore), M Giovinale, U. Massafra(Ospedale San Pietro Fatebenefratelli), Alessandra Soriano, Elena Verrecchia(Università Cattolica del Sacro Cuore), Giuseppe Vittorio De Socio(University of Perugia), C Fonnesu, Valentina Curigliano, Alberto Migliore(Fatebenefratelli Hospital), C. Cerquaglia, M Granata(Ospedale San Filippo Neri)
PubMed
March 1, 2009
Cited by 12

Related Papers

Commensal Clostridia: leading players in the maintenance of gut homeostasis
|Gut Pathogens|2013|753
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
|The Lancet Oncology|2012|550
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 – 74 years and more than 75 years
|BMC Geriatrics|2018|179
Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review
|Seminars in Arthritis and Rheumatism|2018|164
Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores
|Resuscitation|2020|148